1. HBW Insight
  2. >>Health
  3. >>Business
  4. >>Strategy

Sanofi Forms Standalone Consumer Healthcare Unit: Prelude To Spin-Off?

 
• By Tom Gallen

Sanofi Consumer Healthcare is to operate as a standalone unit in a move which is being viewed as a prelude to a potential spin-off. High profile prescription-to-OTC switches are a priority for the revamped business. 

Sanofi plans to operate its Consumer Healthcare unit as a standalone business in a move which is being viewed as a prelude to a potential spin-off.

The French pharma giant’s CEO Paul Hudson – who took the reins in September – outlined his ambition to shake-up...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

GSCF: ‘No One Size Fits All’ Solution To Tricky Sustainable Blister Pack Challenge

 
• By David Ridley

A series of research papers recently published by the Global Self-Care Federation indicate that industry will need to be pragmatic about alternatives to PVC in medicine blister packs.

Moberg Has US Ambitions For Novel Nail Fungus Treatment

 
• By Tom Gallen

Sweden's Moberg wants to introduce its onychomycosis treatment to the US but expects it will need to complete an additional study to win FDA approval.

People On The Move: Appointments At Enzymatica, Haleon, Futura

 
• By Tom Gallen

A round up of the latest moves in Europe's consumer health market: Enzymatica appoints CEO; Haleon hires DACH marketing chief; Futura confirms interim CEO.

Over The Counter: Turning Global Ambition Into Local Reality, With Haleon’s Jo Cooper

 
• By David Ridley

HBW Insight speaks to Haleon's UK & Ireland general manager Jo Cooper about how she plans to translate the firm's ambitious global growth strategy to a local context.

More from Business

Complementary Medicine Move Paying Off For Galenica

 
• By Tom Gallen

Galenica's Swiss consumer health business Verfora is reaping the rewards of its expansion in the complementary medicine market with a solid showing in the first half of the year.

Over The Counter: Turning Global Ambition Into Local Reality, With Haleon’s Jo Cooper

 
• By David Ridley

HBW Insight speaks to Haleon's UK & Ireland general manager Jo Cooper about how she plans to translate the firm's ambitious global growth strategy to a local context.

Prestige Consumer Starting Clear Eyes Production With No Contract Partner ‘Out There To Tap Into’

 
• By Malcolm Spicer

PCH lowers full-year guidance even after reaching $100m deal to acquire Canadian sterile ophthalmic manufacturer for its Clears Eyes line troubled by supply slumps for several years. Its $47.5m reported net sales for April-June period were down 6% from a year ago.